share_log

ネクセラファーマ:Nxera Pharmaは、提携統合失調症候補者のポジティブなフェーズ2データに注目しています。NBI-1117568

Nxera Pharma: Nxera Pharma Notes Positive Phase 2 Data for Partnered Schizophrenia Candidate NBI-1117568

JPX ·  Aug 28 07:05
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more